GlassScriptPhysician profile
Syed Hussain
NPI 1831771872
$3,243.56
in general payments reported to CMS, 2019-2025
21 companies · $2,687 in 2025
The $2,687 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $557 · 2025: $2,687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,433 · Travel and Lodging: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,433.28 |
| Travel and Lodging | $810.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,148.63 | 2025 | Indigo System |
| Lilly USA, LLC | $436.80 | 2024-2025 | Jardiance, Zepbound, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $238.37 | 2024-2025 | |
| Abbvie INC. | $219.30 | 2024-2025 | |
| Novo Nordisk INC | $210.71 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $196.38 | 2025 | Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $186.67 | 2024-2025 | Breztri, Farxiga |
| Renalytix Ai, INC. | $96.49 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Amgen INC. | $88.92 | 2024-2025 | Repatha, Otezla, Evenity |
| Exact Sciences Corporation | $81.91 | 2024-2025 | Cologuard Collection Kit |
| Cashflow Solutions, LLC | $55.37 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Angiodynamics, INC. | $54.65 | 2025 | Auryon Laser System 100-120 Vac |
| Sanofi-Aventis U.S. LLC | $48.21 | 2024 | |
| Boston Scientific Corporation | $28.91 | 2025 | General - Pain Management |
| Dynavax Technologies Corporation | $26.99 | 2025 | Heplisav-B |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $26.23 | 2024 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $24.94 | 2025 | Korlym |
| Si-Bone, INC. | $22.90 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.03 | 2025 | Jardiance |
| Lucid Diagnostics INC. | $15.62 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $13.53 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Hussain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.